White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Not recruiting

4 1 1

+1
Study on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata

Not recruiting

3 1 1
Investigated diseases:
- Alopecia areata
Study on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren’s Disease

Not recruiting

3 1
Investigated diseases:
- Sjogren’s syndrome
Investigated drugs:
- Nipocalimab
+9
Study on the Safety and Tolerability of VRDN-003 for Patients with Thyroid Eye Disease

Not recruiting

3 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- VRDN-003
Study on the Safety and Effectiveness of Anitocabtagene Autoleucel and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

Not recruiting

3 1 1
Investigated diseases:
- Chronic graft versus host disease
Investigated drugs:
- Axatilimab
+8
Study of ISIS 678354 for Patients with Severe High Triglycerides

Not recruiting

3 1
Investigated diseases:
- Familial hypertriglyceridaemia
- Hyperchylomicronaemia
Investigated drugs:
- Isis 678354 Sodium Salt
+9
Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Not recruiting

2 1 1
Investigated drugs:
- ZELENECTIDE PEVEDOTIN
Study on the Use of SB11 Pre-Filled Syringe for Patients with Wet Age-Related Macular Degeneration, Macular Edema from Retinal Vein Occlusion, or Myopic Choroidal Neovascularization

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Ranibizumab
Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

Not recruiting

2 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- IMEROPRUBART
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies